Stock Screener App

무료 -

설치하다

58.78

0.37% -0.24

로열티 파마 (RPRX)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 배당 이력

Royalty Pharma Plc 주식(RPRX)의 최신 뉴스

RPHC5035520 Bond Risk Profile - TradingView

RPHC5237354 Bond Coupon Profile — Rate & Payments - TradingView

Royalty Pharma (NASDAQ:RPRX) Reaches New 1-Year HighShould You Buy? - MarketBeat

RPHC5237354 Bond Profile — Key Metrics - TradingView

RPHC5035520 Bond Coupon Profile — Rate & Payments - TradingView

Neurimmune sells a portion of its royalty interest in cliramitug to Royalty Pharma - marketscreener.com

Bank of New York Mellon Corp Reduces Stock Position in Royalty Pharma PLC $RPRX - MarketBeat

177,500 Shares in Royalty Pharma PLC $RPRX Acquired by Andra AP fonden - MarketBeat

Press Release: Royalty Pharma Declares Third Quarter 2026 Dividend - 富途牛牛

RPHC6166013 Bond Risk Profile - TradingView

RPHC6166013 Bond Profile — Key Metrics - TradingView

Royalty Pharma acquires royalty stake in AstraZeneca drug - Investing.com UK

Royalty Pharma PLC (RPRX) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks

Royalty Pharma acquires royalty stake in AstraZeneca drug By Investing.com - Investing.com South Africa

Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune - marketscreener.com

Royalty Pharma deal includes $125M upfront for heart antibody - Stock Titan

Royalty Pharma PLC $RPRX Shares Bought by Swiss National Bank - MarketBeat

Mediolanum International Funds Ltd Sells 40,296 Shares of Royalty Pharma PLC $RPRX - MarketBeat

SEB Asset Management AB Invests $12.97 Million in Royalty Pharma PLC $RPRX - MarketBeat

California Public Employees Retirement System Cuts Stake in Royalty Pharma PLC $RPRX - MarketBeat

Royalty Pharma PLC $RPRX Holdings Lowered by AlTi Global Inc. - MarketBeat

How (RPRX) Movements Inform Risk Allocation Models - Stock Traders Daily

Hsbc Holdings PLC Acquires 1,486,020 Shares of Royalty Pharma PLC $RPRX - MarketBeat

RPHC5824521 Bond Profile — Key Metrics - TradingView

Royalty Pharma declares $0.235 dividend - MSN

US78081BAP8 Bond Coupon Profile — Rate & Payments - TradingView

RPHC5237916 Bond Coupon Profile — Rate & Payments - TradingView

RPHC5237916 Bond Profile — Key Metrics - TradingView

RPHC6166012 Bond Profile — Key Metrics - TradingView

RPHC6166012 Bond Risk Profile - TradingView

Royalty Pharma declares $0.235 quarterly dividend By Investing.com - Investing.com South Africa

Royalty Pharma declares $0.235 quarterly dividend - Investing.com UK

Royalty Pharma Maintains Quarterly Dividend at $0.235 a Share, Payable on Sept. 10 to Shareholders of Record on Aug. 14 - marketscreener.com

Royalty Pharma Announces Third Quarter 2026 Dividend of $0.235 per Class A Ordinary Share - Quiver Quantitative

Royalty Pharma plc (RPRX) Declares $0.235 Quarterly Dividend; 1.6% Yield - StreetInsider

Royalty Pharma plc Declares Third Quarter 2026 Dividend, Payable on September 10, 2026 - marketscreener.com

Royalty Pharma stock hits all-time high at 58.85 USD By Investing.com - Investing.com South Africa

RPHC6166012 Bond Coupon Profile — Rate & Payments - TradingView

Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month HighHere's Why - MarketBeat

Royalty Pharma stock hits all-time high at 58.85 USD - Investing.com

Royalty Pharma PLC $RPRX Shares Sold by C WorldWide Group Holding A S - MarketBeat

RPHC5824522 Bond Coupon Profile — Rate & Payments - TradingView

Royalty Pharma to announce Q2 2026 financial results on August 5 - scanx.trade

Royalty Pharma schedules 8 a.m. webcast for Aug. 5 results - Stock Titan

RPHC5222527 Bond Profile — Key Metrics - TradingView

Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026 - Yahoo Finance

US78081BAN3 Bond Coupon Profile — Rate & Payments - TradingView

US78081BAN3 Bond Risk Profile - TradingView

Royalty Pharma PLC $RPRX Shares Sold by J. Safra Sarasin Holding AG - MarketBeat

Calamos Advisors LLC Takes Position in Royalty Pharma PLC $RPRX - MarketBeat

RPHC5824522 Bond Risk Profile - TradingView

US78081BAN3 Bond Profile — Key Metrics - TradingView

RPHC5824522 Bond Profile — Key Metrics - TradingView

Calamos Wealth Management LLC Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat

US78081BAQ6 Bond Coupon Profile — Rate & Payments - TradingView

Canal Insurance CO Acquires Shares of 20,000 Royalty Pharma PLC $RPRX - MarketBeat

RPHC5237891 Bond Profile — Key Metrics - TradingView

Royalty Pharma (RPRX) Bernstein Insights: Healthcare Leaders and Disruptors2nd Annual Healthcare Forum summary - Quartr

RPHC5237891 Bond Coupon Profile — Rate & Payments - TradingView

RPHC5237891 Bond Risk Profile - TradingView

US78081BAQ6 Bond Risk Profile - TradingView

US78081BAQ6 Bond Profile — Key Metrics - TradingView

Royalty Pharma (RPRX) Stock Analysis: A Strategic Look At Growth And Valuation Potential - DirectorsTalk Interviews

Royalty Pharma Q1 2026 earnings preview - MSN

World Investment Advisors Sells 48,485 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Royalty Pharma PLC $RPRX is Torray Investment Partners LLC's Largest Position - MarketBeat

Hsbc Holdings PLC Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat

ROIV

$35.36

0.97%

INCY

$117.59

0.83%

BNTX

$91.66

0.31%

ONC

$325.83

0.36%

ALNY

$273.17

1.62%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개